U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H48O
Molecular Weight 388.6694
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIHYDROCHOLESTEROL

SMILES

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI

InChIKey=QYIXCDOBOSTCEI-QCYZZNICSA-N
InChI=1S/C27H48O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-25,28H,6-17H2,1-5H3/t19-,20+,21+,22+,23-,24+,25+,26+,27-/m1/s1

HIDE SMILES / InChI

Molecular Formula C27H48O
Molecular Weight 388.6694
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/9873500 | https://encrypted.google.com/patents/WO2016033735A1 | https://www.ncbi.nlm.nih.gov/pubmed/17544260

Dihydrocholesterol is a cholesterol derivative found in human feces, gallstones, eggs, and other biological matter. Dihydrocholesterol was effective in reducing plasma cholesterol. Plasma total cholesterol-lowering activity of Dihydrocholesterol was mediated by inhibiting the cholesterol absorption and increasing the fecal sterol excretion.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q12770
Gene ID: 22937.0
Gene Symbol: SCAP
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure-activity relationships.
2015-06-05
A comparative study of the sulfation of bile acids and a bile alcohol by the Zebra danio (Danio rerio) and human cytosolic sulfotransferases (SULTs).
2011-11
Cholesterol induces specific spatial and orientational order in cholesterol/phospholipid membranes.
2010-06-17
Influence of the nature of the sterol on the behavior of palmitic acid/sterol mixtures and their derived liposomes.
2010-06
Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae.
2009-09-15
Critical exponents for line tension and dipole density difference from lipid monolayer domain boundary fluctuations.
2008-07-10
Comparison of the interaction of dihydrocholesterol and cholesterol with sphingolipid or phospholipid Langmuir monolayers.
2007-09-01
Insertion selectivity of antimicrobial peptide protegrin-1 into lipid monolayers: effect of head group electrostatics and tail group packing.
2006-09
Thermodynamic equilibrium of domains in a two-component Langmuir monolayer.
2006-07-15
Phase behavior of lipid monolayers containing DPPC and cholesterol analogs.
2006-05-01
Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
2006-04-15
An efficient diethyl ether-based soxhlet protocol to quantify faecal sterols from catchment waters.
2006-03-03
Method validation for the simultaneous determination of fecal sterols in surface waters by gas chromatography-mass spectrometry.
2006-02
Structural requirements of cholesterol for binding to Vibrio cholerae hemolysin.
2006
Impact of membrane cholesterol content on the resistance of vesicles to surfactant attack.
2005-10-25
Kinetics for the collapse of trilayer liquid-crystalline disks from a monolayer at an air-water interface.
2005-08-02
Impact of 10 dietary sterols on growth and reproduction of Daphnia galeata.
2004-03
Contrast inversion in the epifluorescence of cholesterol-phospholipid monolayers.
2004-02
Unraveling the mystery surrounding cholesterol's condensing effect.
2003-12-31
Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain.
2003-12-09
[Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
2002-12
Two fatty acids can replace one phospholipid in condensed complexes with cholesterol.
2002-08-19
Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1).
2002-07-01
A new method for determination of serum cholestanol by high-performance liquid chromatography with ultraviolet detection.
2000-06-09
Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis.
2000-04
The metabolism of cholestanol in primary biliary cirrhosis.
1996-04
High-performance liquid chromatographic determination of cholesterol and cholestanol in human serum by precolumn derivatization with 2-[2-(isocyanate)ethyl]-3-methyl-1,4-naphthoquinone combined with platinum catalyst reduction and electrochemical detection.
1995-12
Liver transplantation modifies serum cholestanol, cholesterol precursor and plant sterol levels.
1992-06-30
[Cerebrotendinous xanthomatosis].
1991-06-08
Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
1987-05-14
Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis.
1987-03
Cholesterol precursor sterols, plant sterols, and cholestanol in human bile and gallstones.
1986-04
A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
1985-02
Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
1984-08
Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis).
1984-03-13
Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.
1983-05
Simplified determination of cholestanol in serum by gas-liquid chromatography: biochemical diagnosis of cerebrotendinous xanthomatosis.
1981-07
Patents

Sample Use Guides

In Vivo Use Guide
Rabbits fed a diet containing 0.75% dihydrocholesterol for 7 days
Route of Administration: Oral
On day 0, CHO-K1 cells were set up for experiments in medium B at 7 x 10^5 cells per 100-mm dish and cultured at 37°C. On day 2, the cells were switched to medium D containing 1% HPCD for 1 h. The cells were then washed twice with PBS and switched to medium D containing 20 mkM concentrations of Dihydrocholesterol complexed in a 1:12 molar ratio with MCD. Stock solutions of sterol–MCD complexes at a final sterol concentration of 2.5 mM. After incubation for 6 h, the cells were washed once with PBS, then treated with 300 mkl of Buffer D and scraped into 1.5-ml tubes. The cells were passed through a 22-gauge needle 15 times and then agitated for 10 min. The protein concentration of each cell extract was measured (BCA kit), after which an aliquot of cell extract (25 mkg) was mixed with an equal volume of Laemmli sample buffer (Bio-Rad), heated for 10 min at 95°C, and then subjected to 8% SDS/PAGE and immunoblot detection of SREBP-2.
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:09:01 GMT 2025
Edited
by admin
on Mon Mar 31 19:09:01 GMT 2025
Record UNII
8M308U816E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIHYDROCHOLESTEROL
INCI  
INCI  
Official Name English
ZYMOSTANOL
Preferred Name English
CHOLESTANOL [USP-RS]
Common Name English
CHOLESTAN-3-OL,(3.BETA.,5.ALPHA.)-
Common Name English
DIHYDROCHOLESTERIN
Common Name English
CHOLESTANOL [MI]
Common Name English
NSC-18188
Code English
Code System Code Type Description
RS_ITEM_NUM
1131858
Created by admin on Mon Mar 31 19:09:01 GMT 2025 , Edited by admin on Mon Mar 31 19:09:01 GMT 2025
PRIMARY
CAS
80-97-7
Created by admin on Mon Mar 31 19:09:01 GMT 2025 , Edited by admin on Mon Mar 31 19:09:01 GMT 2025
PRIMARY
CHEBI
86570
Created by admin on Mon Mar 31 19:09:01 GMT 2025 , Edited by admin on Mon Mar 31 19:09:01 GMT 2025
PRIMARY
MERCK INDEX
m3477
Created by admin on Mon Mar 31 19:09:01 GMT 2025 , Edited by admin on Mon Mar 31 19:09:01 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
201-315-8
Created by admin on Mon Mar 31 19:09:01 GMT 2025 , Edited by admin on Mon Mar 31 19:09:01 GMT 2025
PRIMARY
PUBCHEM
6665
Created by admin on Mon Mar 31 19:09:01 GMT 2025 , Edited by admin on Mon Mar 31 19:09:01 GMT 2025
PRIMARY
EPA CompTox
DTXSID40883258
Created by admin on Mon Mar 31 19:09:01 GMT 2025 , Edited by admin on Mon Mar 31 19:09:01 GMT 2025
PRIMARY
FDA UNII
8M308U816E
Created by admin on Mon Mar 31 19:09:01 GMT 2025 , Edited by admin on Mon Mar 31 19:09:01 GMT 2025
PRIMARY
NSC
18188
Created by admin on Mon Mar 31 19:09:01 GMT 2025 , Edited by admin on Mon Mar 31 19:09:01 GMT 2025
PRIMARY